表紙
市場調查報告書

全球皮下藥物輸送市場:規模,佔有率,趨勢,及預測

Subcutaneous Drug Delivery Market - Global Forecast to 2026, by Usability, by Disease Indication, by Delivery Type, by Distribution Channel and by Region - Size, Share, Trends, and Forecast 2018 - 2026

出版商 Coherent Market Insights 商品編碼 906232
出版日期 內容資訊 英文 237 Pages
商品交期: 2-3個工作天內
價格
Back to Top
全球皮下藥物輸送市場:規模,佔有率,趨勢,及預測 Subcutaneous Drug Delivery Market - Global Forecast to 2026, by Usability, by Disease Indication, by Delivery Type, by Distribution Channel and by Region - Size, Share, Trends, and Forecast 2018 - 2026
出版日期: 2019年07月30日內容資訊: 英文 237 Pages
簡介

本報告提供全球皮下藥物輸送市場的相關調查,提供市場機會和趨勢,成長及阻礙因素,各效用·疾病適應症·給藥類型·流通管道·地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 調查的目的及假設

  • 調查目的
  • 假設
  • 簡稱

第2章 市場範圍

  • 報告的說明
    • 市場定義及範圍
  • 摘要整理
    • 各效用
    • 各疾病適應症
    • 各給藥類型
    • 各流通管道
    • 各地區
  • COM (Coherent Opportunity Map)

第3章 市場動態,法規,趨勢分析

  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 市場趨勢
  • 主要的開發
  • 法規方案
  • 償付方案
  • 合併及收購方案
  • PEST分析
  • 流行病學

第4章 皮下藥物輸送的全球市場:各效用

  • 簡介
  • 拋棄式
  • 可重複使用

第5章 皮下藥物輸送的全球市場:各疾病適應症

  • 簡介
  • 自體免疫疾病
  • 神經學的障礙
  • 腫瘤疾病
  • 荷爾蒙障礙
  • 過敏及感染疾病
  • 眼科疾病
  • 其他

第6章 皮下藥物輸送的全球市場:各給藥類型

  • 簡介
  • 預填充式注射器
  • 注射
  • 預填充式筆
  • 管瓶(注射器)
  • 幫浦以及其他

第7章 皮下藥物輸送的全球市場:各流通管道

  • 簡介
  • 醫院藥局
  • 零售藥局
  • 線上藥局

第8章 皮下藥物輸送的全球市場:各地區

  • 簡介
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第9章 競爭情形

  • 熱圖分析
  • 市場佔有率分析
    • Becton Dickinson and Company*
    • Novo Nordisk A/S
    • Johnson & Johnson
    • Sanofi S.A.
    • Teva Pharmaceutical Industries Ltd.
    • Amgen, Inc.
    • F. Hoffmann-La Roche AG
    • Consort Medical plc
    • Eli Lilly and Company
    • Merck & Co., Inc.
  • 分析師的見解

第10章 章節

  • 參照資料
  • 調查方法
  • 關於Coherent Market Insight
目錄

Title:
Subcutaneous Drug Delivery Market - Global Forecast to 2026, by Usability (Disposable and Reusable), by Disease Indication (Auto-immune Disorders, Neurological Disorders, Oncology Disorders, Hormonal Disorders, Allergy and Infectious Disorders, Ophthalmic Disorders, and Others), by Delivery Type (Prefilled Syringe, Injector, Prefilled Pen, Vial (Syringe), Pump, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, and Forecast 2018 - 2026.

The market comprises of products, which are available in reusable and disposable form. Disposable segment is expected to witness growth, owing to significant increase in self-administration of drugs to treat chronic diseases. Moreover, the shift from vial-and-syringe format, which is prone to dosing errors and low patient-compliance rates to prefilled syringes that enable the use of disposable and single-use syringes already filled with a prescribed unit dose of medication, is expected to enhance the market growth.

Market Dynamics:

Technological innovations and developments in prefilled syringes and auto-injectors is contributing to the market growth. For instance, Gerresheimer introduced metal-free Luer Lock Gx RTF Syringe in 2017, without tungsten to create perfect primary packaging material for biotechnologically manufactured active ingredients that ideally exclude the possibility of contamination with metal. However, higher cost of auto-injectors and product recalls are factors expected to restrain the market growth.

Key features of the study:

  • This report provides in-depth analysis of the global subcutaneous drug delivery market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2018-2026), considering 2017 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global subcutaneous drug delivery market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Becton Dickinson and Company, Novo Nordisk A/S, Johnson & Johnson, Sanofi S.A., Novartis International AG, Amgen, Inc., Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche AG, Consort Medical plc, Eli Lilly and Company, and Merck & Co., Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global subcutaneous drug delivery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global subcutaneous drug delivery market

Detailed Segmentation:

  • Global Subcutaneous Drug Delivery Market, By Usability:
    • Disposable
    • Reusable
  • Global Subcutaneous Drug Delivery Market, By Disease Indication:
    • Auto-immune Disorders
    • Neurological Disorders
    • Oncology Disorders
    • Hormonal Disorders
    • Allergy & Infectious Disorders
    • Ophthalmic Disorders
    • Others
  • Global Subcutaneous Drug Delivery Market, By Delivery Type:
    • Prefilled Syringe
    • Injector
    • Prefilled Pen
    • Vial (Syringe)
    • Pump and Others
  • Global Subcutaneous Drug Delivery Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Subcutaneous Drug Delivery Market, By Region:
    • North America
      • By Usability:
      • Disposable
      • Reusable
      • By Disease Indication:
      • Auto-immune Disorders
      • Neurological Disorders
      • Oncology Disorders
      • Hormonal Disorders
      • Allergy & Infectious Disorders
      • Ophthalmic Disorders
      • Others
      • By Delivery Type:
      • Prefilled Syringe
      • Injector
      • Prefilled Pen
      • Vial (Syringe)
      • Pump and Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Usability:
      • Disposable
      • Reusable
      • By Disease Indication:
      • Auto-immune Disorders
      • Neurological Disorders
      • Oncology Disorders
      • Hormonal Disorders
      • Allergy & Infectious Disorders
      • Ophthalmic Disorders
      • Others
      • By Delivery Type:
      • Prefilled Syringe
      • Injector
      • Prefilled Pen
      • Vial (Syringe)
      • Pump and Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Usability:
      • Disposable
      • Reusable
      • By Disease Indication:
      • Auto-immune Disorders
      • Neurological Disorders
      • Oncology Disorders
      • Hormonal Disorders
      • Allergy & Infectious Disorders
      • Ophthalmic Disorders
      • Others
      • By Delivery Type:
      • Prefilled Syringe
      • Injector
      • Prefilled Pen
      • Vial (Syringe)
      • Pump and Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Usability:
      • Disposable
      • Reusable
      • By Disease Indication:
      • Auto-immune Disorders
      • Neurological Disorders
      • Oncology Disorders
      • Hormonal Disorders
      • Allergy & Infectious Disorders
      • Ophthalmic Disorders
      • Others
      • By Delivery Type:
      • Prefilled Syringe
      • Injector
      • Prefilled Pen
      • Vial (Syringe)
      • Pump and Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Usability:
      • Disposable
      • Reusable
      • By Disease Indication:
      • Auto-immune Disorders
      • Neurological Disorders
      • Oncology Disorders
      • Hormonal Disorders
      • Allergy & Infectious Disorders
      • Ophthalmic Disorders
      • Others
      • By Delivery Type:
      • Prefilled Syringe
      • Injector
      • Prefilled Pen
      • Vial (Syringe)
      • Pump and Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country/Region:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Usability:
      • Disposable
      • Reusable
      • By Disease Indication:
      • Auto-immune Disorders
      • Neurological Disorders
      • Oncology Disorders
      • Hormonal Disorders
      • Allergy & Infectious Disorders
      • Ophthalmic Disorders
      • Others
      • By Delivery Type:
      • Prefilled Syringe
      • Injector
      • Prefilled Pen
      • Vial (Syringe)
      • Pump and Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Becton, Dickinson and Company*
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Novo Nordisk A/S
    • Johnson & Johnson
    • Sanofi S.A.
    • Teva Pharmaceutical Industries Ltd.
    • Amgen, Inc.
    • F. Hoffmann-La Roche AG
    • Consort Medical plc
    • Eli Lilly and Company
    • Merck & Co., Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Usability
    • Market Snippet, By Disease Indication
    • Market Snippet, By Delivery Type
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Reimbursement Scenario
  • Merger and Acquisition Scenario
  • PEST Analysis
  • Epidemiology

4. Global Subcutaneous Drug Delivery Market, By Usability, 2016 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2016 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Disposable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Reusable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

5. Global Subcutaneous Drug Delivery Market, By Disease Indication, 2016 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2016 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Auto-immune Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Neurological Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Oncology Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Hormonal Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Allergy & Infectious Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Ophthalmic Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

6. Global Subcutaneous Drug Delivery Market, By Delivery System, 2016 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2016 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Prefilled Syringe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Injector
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Prefilled Pen
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Vial (Syringe)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Pump and Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

7. Global Subcutaneous Drug Delivery Market, By Distribution Channel, 2016 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2016 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

8. Global Subcutaneous Drug Delivery Market, By Region, 2016 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2016 and 2026 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
  • North America
    • Market Size and Forecast, By Usability, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Delivery System, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Usability, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Delivery System, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Usability, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Delivery System, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Usability, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Delivery System, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Usability, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Delivery System, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country/Region, 2016 - 2026, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Usability, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Delivery System, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country/Region, 2016 - 2026, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

9. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • Becton Dickinson and Company*
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Novo Nordisk A/S
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Johnson & Johnson
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sanofi S.A.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Teva Pharmaceutical Industries Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Amgen, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • F. Hoffmann-La Roche AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Consort Medical plc
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Eli Lilly and Company
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Merck & Co., Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About Us and Sales Contact
Back to Top